What you should know:
1. Cantel could pay up to $10.5 million for Vista, $7 million in upfront cash and $3.5 million in incentives.
2. Vista Research Group had approximately $2 million in total sales in 2018.
3. Vista’s water treatment portfolio is centered around reducing the risk of infections and improving patient care.
4. Cantel Medical President and CEO Jorgen Hansen said, ” We’re excited that Vista Research Group is now part of Cantel. The integration of their water treatment technologies into our existing portfolio allows us to offer our customers more comprehensive infection prevention solutions that provide clean water across all touchpoints in the dental clinic.”
More articles on gastroenterology:
What GI practices should look for in a PE partner — 5 Qs with Provident’s Abe M’Bodj
84 regional income, case mix benchmarks for ASCs to know
Why an Oklahoma-based ASC values autonomy — 3 insights
